UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549  

 

 

FORM 8-K 

 

CURRENT REPORT 

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 

 

 

Date of Report: April 26, 2012 

(Date of earliest event reported): 

 

 

INNODATA ISOGEN, INC.

(Exact name of registrant as specified in its charter) 

 

 

 

Delaware 0-22196 13-3475943
(State or other jurisdiction of (Commission File Number) (I.R.S. Employer
incorporation)                     Identification No.)

 

 

Three University Plaza   07601
Hackensack, NJ 07601   (Zip Code)
(Address of principal executive offices)    

 

 

(201) 371-8000
(Registrant's telephone number, including area code)
 
N/A
(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

£  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

£  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

£  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

£  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

  

 

 

  

Item 2.02Results of Operations and Financial Condition.

 

On April 26, 2012, Innodata Isogen, Inc. issued a press release announcing its first quarter 2012 financial results. A copy of the press release is attached hereto as Exhibit 99.1.

 

In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

  

Item 9.01Financial Statements and Exhibits.

 

99.1Press release dated April 26, 2012.

 

2
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  INNODATA ISOGEN, INC.
     
Date:  April 26, 2012 By: /s/ O’Neil Nalavadi
    O’Neil Nalavadi
    Senior Vice President and Chief Financial Officer

 

 

3
 

 

 

INDEX TO EXHIBITS

 

 

Exhibit No.     Description  
  99.1        Press Release of Innodata Isogen, Inc., dated April 26, 2012, reporting first quarter 2012 financial results.
               

 

4